Shijiazhuang Yiling Pharmaceutical Co Ltd (002603 SHE) stock market data APIs
¥14.9265
-0.08(-0.5%)
as of July 11, 2025
Try our APIs with
free plan!
Shijiazhuang Yiling Pharmaceutical Co Ltd Financial Data Overview
Price chart is built with
Anychart
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for respiratory health, cardiovascular disease, diabetes mellitus, oncology, urologic disease, sleep-improving, and anti-aging. The company also provides dietary supplements, health food and drinks, disinfection products, and personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.
Prev. Close
14.9265
Open
14.8475
High
14.8658
Low
14.8197
52 wk Range
12.41-19.82
Market Cap
24 910 M
Shares Outstanding
1 671 M
Revenue
6 348 M
EPS
-0.7657
Dividends (Yield)
0.0213
Beta
0.585
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Shijiazhuang Yiling Pharmaceutical Co Ltd data using free add-ons & libraries
Get Shijiazhuang Yiling Pharmaceutical Co Ltd Fundamental Data
Shijiazhuang Yiling Pharmaceutical Co Ltd Fundamental data includes:
- Net Revenue: 6 348 M
- EBITDA: -193 556 624
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Shijiazhuang Yiling Pharmaceutical Co Ltd Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: 2025-04-29
- EPS/Forecast: NaN
Get Shijiazhuang Yiling Pharmaceutical Co Ltd End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Shijiazhuang Yiling Pharmaceutical Co Ltd News
New
Chinese drug makers’ shares plunge as Pfizer’s Paxlovid gains market share
Shares of Chinese pharmaceutical companies plunged Tuesday morning on Chinese bourses, continuing a slide that began in the face of competition from Pfizer's COVID-19 drug Paxlovid earlier this month. Continue reading
Approaching Covid Wave Tests China’s Embrace of Herbal Remedies
After China announced it would ease its strict pandemic restrictions, sales of popular traditional medicine are surging. Continue reading
An unproven herbal covid pill is a big winner in Beijing’s new pandemic rules
A woman gets tested for covid in Shanghai, China. Beijing’s announcement last Friday (Nov. 11) of marginally revised covid rules kicked off an optimistic surge in Chinese stocks. One of the biggest...
Yiling's Lianhua Health Products Well-received: CICPE
SHIJIAZHUANG, China, Aug. 5, 2022 /PRNewswire/ -- As China's first national-level consumer expo and the largest such kind in the Asia-pacific region, the 2nd China International Consumer Products Exp...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
